Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

FTSE 100 slips as COVID cases jump; but marks fifth consecutive monthly gain

Published 30/06/2021, 08:37
Updated 30/06/2021, 17:15
© Reuters. A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London, Britain, October 1, 2008.  REUTERS/Toby Melville/File Photo

By Shashank Nayar and Amal S

(Reuters) -London's FTSE 100 fell on Wednesday on concerns that a recent jump in coronavirus infections could hinder the pace of economic growth, taking the shine off the fifth straight monthly gain for the blue-chip index.

The FTSE 100 eased 0.7%, but clocked its best monthly winning streak since 2016.

Heavyweight financials led declines, down 0.7%, followed by base and precious metal miners which were down 1.2% and 0.8% respectively.

The index has gained 8.9% so far this year to stand just under 12% away from its record high. However, it has significantly underperformed its European peers with the STOXX 600 hovering near its all-time high, as inflation concerns and rising COVID-19 infections hinder the recovery process.

"There is a sense of general unease at the moment as we're seeing a rise in the number of Delta variant cases, while we're just under three weeks away from what is supposed to be 'Freedom Day' for the UK," said Danni Hewson, analyst at AJ Bell.

Retailers slipped 0.4% after an industry group said growing costs linked to COVID-19 and Brexit might add to the rise in broader inflation soon.

"Investors are just taking a look at the support mechanisms winding down, "Hewson said, referring to business rates support and the furlough scheme.

"Then wondering whether or not the economy really is going to open up and then trying to balance that with rising prices."

The domestically focussed mid-cap index slipped 0.7%

Dixons Carphone (LON:DC) jumped 5.9% after the electricals retailer reported a 34% rise in annual profit.

Opioid addiction treatment maker Indivior Plc rose 6.4% to the top of the FTSE 250 index after it said its 2021 revenue and profit would be significantly above its previous outlook.

© Reuters. A worker shelters from the rain under a Union Flag umbrella as he passes the London Stock Exchange in London, Britain, October 1, 2008.  REUTERS/Toby Melville/File Photo

Non-Standard Finance slid 23%, after the British sub-prime lender said it plans to close its guarantor loans division.

Automakers fell 1.1% after car dealership Pendragon warned that vehicle orders were being delayed due to a global chip shortage and flagged further supply constraints in the second half.

Latest comments

Britons had a taste of freedom. Now they want to slosh about in beer gardens watching the footie. Not even the virus can deter a rowdy gathering 🍻
'as cases jump' what a rubbish headline
Growing cases show how effective is vaccine...
Vaccine is highly effective, cases up but hospital admissions are nowhere close to last year's numbers. We just have to accept Covid is part of the human disease pool the affects of which can be mitigated by vaccination. Other therapies are being developed like monoclonal antibodies too.
learn to live with it like we do with any pathogen If we start flapping at every variant we will never get out of this hole
noone will tell how many deaths is now and how many will.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.